Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 277

Results For "CENT"

4872 News Found

Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’
Drug Approval | September 21, 2023

Biocon Biologics receives European Commission approval for biosimilar of Aflibercept ‘Yesafili’

The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway


Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia
News | September 21, 2023

Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia

With this, the company has secured 511 marketing approvals for its oncology products across 66 countries


Parexel appoints Gwyn Bebb to lead oncology clinical development
People | September 21, 2023

Parexel appoints Gwyn Bebb to lead oncology clinical development

Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need


Apollo Telehealth revolutionizes healthcare access through innovation
Healthcare | September 20, 2023

Apollo Telehealth revolutionizes healthcare access through innovation

Apollo Telehealth has established more than 700 centers, in 7 states


Biovyn PVC to be used in sustainable prosthetics for the first time
News | September 20, 2023

Biovyn PVC to be used in sustainable prosthetics for the first time

Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell


Cenexi appoints Jim McPherson as CEO
People | September 20, 2023

Cenexi appoints Jim McPherson as CEO

Prior to this, Jim held leadership positions at several companies, including Centrient Pharmaceuticals, Leo Pharmaceuticals, Sandoz, Xellia, and GSK


CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData
Clinical Trials | September 19, 2023

CureVac highlights shift to mRNA technology in seasonal influenza vaccine development: GlobalData

CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology


Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
Drug Approval | September 19, 2023

Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia

Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy


CAHO and PFPSF launch Patient Advisory Councils
Healthcare | September 18, 2023

CAHO and PFPSF launch Patient Advisory Councils

Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery


Merck receives positive EU CHMP opinion for Keytruda as adjuvant treatment for  cell lung cancer
Drug Approval | September 18, 2023

Merck receives positive EU CHMP opinion for Keytruda as adjuvant treatment for cell lung cancer

Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial